Metastatic Pancreatic Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct s, Metastatic Pancreatic Cancer - Pipeline Review, H2 2015, provides an overview of the Metastatic Pancreatic Cancer s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Metastatic Pancreatic Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Pancreatic Cancer and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/Universi